Physician profile
Gary S Gottesman
NPI 1447269444
$28,287.34
in general payments reported to CMS, 2019-2025
3 companies · $15K in 2025
The $15K reported for 2025 was more than what 88% of Clinical Genetics (M.D.) providers received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.58 · 2020: $2,777 · 2021: $691 · 2022: $79.98 · 2023: $9,839 · 2024: $103 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $1,887 · Food and Beverage: $450 · Education: $30.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,338.25 |
| Travel and Lodging | $1,886.51 |
| Food and Beverage | $449.53 |
| Education | $30.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $17,236.97 | 2023-2025 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $11,032.27 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $18.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gottesman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.